NCT04575961
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04575961
Title Study of Pembrolizumab Combination With Chemotherapy in Platinum-sensitive Recurrent Low-grade Serous Ovarian Cancer (PERCEPTION)
Acronym PERCEPTION
Recruitment Active, not recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors North Eastern German Society of Gynaecological Oncology
Indications
Therapies
Age Groups: senior | adult
Covered Countries DEU

Facility Status City State Zip Country Details
Charité - Universitätsmedizin Berlin, Campus Virchow Klinikum Berlin 13353 Germany Details
Kliniken Essen Mitte Essen 45136 Germany Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field